Jack C. Huang

Jack C. Huang

Gastroenterology

14010 Smoketown Rd
117
Woodbridge, VA 22192

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004).

FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 08, 2024

Showing 1-1 of 1

Last Updated: 09/26/2026